{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:01:26Z","timestamp":1793512886850,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Shanghai Sailing Program","award":["18YF1422700"],"award-info":[{"award-number":["18YF1422700"]}]},{"name":"Starting Foundation for Young Scientists of Second Military Medical University","award":["2017QN10"],"award-info":[{"award-number":["2017QN10"]}]},{"name":"Starting Foundation for Young Scientists of Second Military Medical University","award":["2017QN11"],"award-info":[{"award-number":["2017QN11"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81772720"],"award-info":[{"award-number":["81772720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81572509"],"award-info":[{"award-number":["81572509"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81802515"],"award-info":[{"award-number":["81802515"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81801854"],"award-info":[{"award-number":["81801854"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.urolonc.2018.12.027","type":"journal-article","created":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T22:03:47Z","timestamp":1546985027000},"page":"290.e17-290.e24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy"],"prefix":"10.1016","volume":"37","author":[{"given":"Shuxiong","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihe","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huamao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguo","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhensheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2018.12.027_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.eururo.2017.07.036","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2017 Update","volume":"73","author":"Roupret","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0002","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/bju.14020","volume":"121","author":"Necchi","year":"2018","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0003","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1016\/j.juro.2018.02.579","article-title":"Results of pout-a phase III randomised trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC)","volume":"199","author":"Birtle","year":"2018","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0004","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1200\/JCO.2016.69.4141","article-title":"Effectiveness of adjuvant chemotherapy after radical nephroureterectomy for locally advanced and\/or positive regional lymph node upper tract urothelial carcinoma","volume":"35","author":"Seisen","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0005","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1464-410X.2006.06524.x","article-title":"Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm?","volume":"98","author":"Brown","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0006","first-page":"6566","article-title":"Endoscopic biopsy of upper tract tumors: why bother?","volume":"19","author":"Keeley","year":"2012","journal-title":"Can J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0007","doi-asserted-by":"crossref","first-page":"e751","DOI":"10.1016\/j.clgc.2018.01.014","article-title":"Prognostic factors and risk stratification in invasive upper tract urothelial carcinoma","volume":"16","author":"Emamekhoo","year":"2018","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0008","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.eururo.2012.01.021","article-title":"Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma","volume":"61","author":"Cha","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0009","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1200\/JCO.2007.14.1291","article-title":"Individualized prediction of colon cancer recurrence using a nomogram","volume":"26","author":"Weiser","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0010","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.purol.2014.07.013","article-title":"[Prognostic factors of upper tract urothelial carcinomas and impact on survival: a systematic review for the yearly scientific report of the French National Association of Urology]","volume":"24","author":"Colin","year":"2014","journal-title":"Prog Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0011","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jjco\/hyy084","article-title":"Preoperative risk classification using neutrophil-lymphocyte ratio and hydronephrosis for upper tract urothelial carcinoma","volume":"48","author":"Kohada","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0012","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00345-015-1715-0","article-title":"The prognostic impact of squamous and glandular differentiation for upper tract urothelial carcinoma patients after radical nephroureterectomy","volume":"34","author":"Tang","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0013","first-page":"12701","article-title":"Sarcopenia is an independent predictor of survival outcomes for patients with upper tract urothelial carcinoma","volume":"9","author":"Gao","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0014","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","article-title":"Evaluating the yield of medical tests","volume":"247","author":"Harrell","year":"1982","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0015","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0016","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0017","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0018","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0019","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25122","article-title":"Highly predictive survival nomogram after upper urinary tract urothelial carcinoma","volume":"116","author":"Jeldres","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0020","doi-asserted-by":"crossref","first-page":"88 e11","DOI":"10.1016\/j.urolonc.2017.10.029","article-title":"Preoperative predictors of nonorgan-confined disease in upper-tract urothelial carcinoma differ between China and the United States","volume":"36","author":"Singla","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0021","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.juro.2016.11.094","article-title":"A Multi-institutional comparison of clinicopathological characteristics and oncologic outcomes of upper tract urothelial carcinoma in China and the United States","volume":"197","author":"Singla","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0022","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1464-410X.2012.10930.x","article-title":"International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis","volume":"110","author":"Roscigno","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0023","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1007\/s00345-015-1566-8","article-title":"TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma","volume":"33","author":"Youssef","year":"2015","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0024","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.4103\/0366-6999.213414","article-title":"Validation of the pretreatment neutrophil-to-lymphocyte ratio as a prognostic factor in a large cohort of Chinese Patients with upper tract urothelial carcinoma","volume":"130","author":"Cao","year":"2017","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0025","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1016\/j.clgc.2016.04.017","article-title":"Histopathologic characteristics of upper tract urothelial carcinoma with an emphasis on their effect on cancer survival: a single-institute experience with 305 Patients with long-term follow-up","volume":"14","author":"Elawdy","year":"2016","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0026","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000362248","article-title":"Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomy","volume":"93","author":"Aziz","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0027","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00345-018-2235-5","article-title":"Is neutrophil-to-lymphocytes ratio a clinical relevant preoperative biomarker in upper tract urothelial carcinoma? A meta-analysis of 4385 patients","volume":"36","author":"Vartolomei","year":"2018","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0028","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00345-016-1871-x","article-title":"HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0029","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1038\/srep06361","article-title":"The impact of tumor location and multifocality on prognosis for patients with upper tract urothelial carcinoma: a meta-analysis","volume":"4","author":"Wu","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0030","doi-asserted-by":"crossref","first-page":"e6945","DOI":"10.1097\/MD.0000000000006945","article-title":"Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: a retrospective cohort study","volume":"96","author":"Qin","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0031","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1097\/PAS.0b013e3182159dec","article-title":"Sarcomatoid carcinoma of the urinary bladder: the final common pathway of urothelial carcinoma dedifferentiation","volume":"35","author":"Cheng","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0032","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/jjco\/hyx030","article-title":"Impact of divergent differentiation in urothelial carcinoma on oncological outcome in patients with T1 high-grade bladder cancer","volume":"47","author":"Fujii","year":"2017","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0033","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.eururo.2011.05.049","article-title":"Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy","volume":"60","author":"Ouzzane","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0034","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0035","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00345-013-1045-z","article-title":"Impact of the length of time between diagnosis and surgical removal of urologic neoplasms on survival","volume":"32","author":"Bourgade","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0036","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1464-410X.2009.08821.x","article-title":"A delay in radical nephroureterectomy can lead to upstaging","volume":"105","author":"Waldert","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0037","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S1470-2045(17)30616-2","article-title":"First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study","volume":"18","author":"Balar","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0038","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.urolonc.2018.12.027_bib0039","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nature13904","article-title":"MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer","volume":"515","author":"Powles","year":"2014","journal-title":"Nature"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918305532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143918305532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:14:39Z","timestamp":1761041679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143918305532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S1078143918305532"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.12.027","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and external validation of a nomogram predicting prognosis of upper tract urothelial carcinoma after radical nephroureterectomy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2018.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}